BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $158,119 | -37.4% | 4,090 | -38.9% | 0.04% | -42.0% |
| Q3 2023 | $252,481 | -17.2% | 6,690 | 0.0% | 0.07% | -13.8% |
| Q2 2023 | $304,796 | +3.8% | 6,690 | -7.6% | 0.08% | -2.4% |
| Q1 2023 | $293,654 | -24.6% | 7,240 | -5.2% | 0.08% | -23.4% |
| Q4 2022 | $389,410 | -21.3% | 7,640 | -17.0% | 0.11% | -23.6% |
| Q3 2022 | $495,000 | -17.1% | 9,201 | -1.1% | 0.14% | -10.3% |
| Q2 2022 | $597,000 | -20.7% | 9,301 | -4.3% | 0.16% | -3.1% |
| Q1 2022 | $753,000 | -4.8% | 9,716 | +5.4% | 0.16% | -1.8% |
| Q4 2021 | $791,000 | +6.6% | 9,216 | -0.1% | 0.16% | -2.4% |
| Q3 2021 | $742,000 | +3.3% | 9,226 | +3.4% | 0.17% | +2.4% |
| Q2 2021 | $718,000 | -10.6% | 8,925 | -6.3% | 0.16% | -18.0% |
| Q1 2021 | $803,000 | -0.1% | 9,525 | -5.0% | 0.20% | +9.3% |
| Q4 2020 | $804,000 | -19.9% | 10,025 | -19.7% | 0.18% | -26.5% |
| Q3 2020 | $1,004,000 | -7.3% | 12,491 | -0.8% | 0.25% | -14.1% |
| Q2 2020 | $1,083,000 | +0.3% | 12,591 | -5.4% | 0.29% | -9.7% |
| Q1 2020 | $1,080,000 | -4.3% | 13,307 | -1.5% | 0.32% | +26.4% |
| Q4 2019 | $1,129,000 | -9.2% | 13,507 | -5.1% | 0.25% | -12.1% |
| Q3 2019 | $1,243,000 | +6.7% | 14,230 | 0.0% | 0.29% | +9.9% |
| Q2 2019 | $1,165,000 | +10.5% | 14,230 | +2.9% | 0.26% | +9.6% |
| Q1 2019 | $1,054,000 | +15.8% | 13,830 | +0.0% | 0.24% | +0.8% |
| Q4 2018 | $910,000 | -16.4% | 13,829 | -2.1% | 0.24% | 0.0% |
| Q3 2018 | $1,089,000 | +4.4% | 14,129 | 0.0% | 0.24% | -0.8% |
| Q2 2018 | $1,043,000 | +8.2% | 14,129 | -4.7% | 0.24% | +7.6% |
| Q1 2018 | $964,000 | -3.3% | 14,829 | -3.9% | 0.22% | -3.5% |
| Q4 2017 | $997,000 | +3.0% | 15,428 | +0.0% | 0.23% | -1.3% |
| Q3 2017 | $968,000 | +0.3% | 15,427 | -4.3% | 0.23% | -2.5% |
| Q2 2017 | $965,000 | +12.1% | 16,127 | -23.4% | 0.24% | +11.1% |
| Q1 2017 | $861,000 | +9.0% | 21,048 | -5.4% | 0.22% | +1.4% |
| Q4 2016 | $790,000 | -4.1% | 22,248 | +2.3% | 0.21% | -8.6% |
| Q3 2016 | $824,000 | +3.5% | 21,741 | -1.4% | 0.23% | 0.0% |
| Q2 2016 | $796,000 | +12.0% | 22,041 | +27.4% | 0.23% | +8.9% |
| Q1 2016 | $711,000 | +6.4% | 17,307 | -1.1% | 0.21% | +10.9% |
| Q4 2015 | $668,000 | +29.5% | 17,507 | +11.5% | 0.19% | +35.9% |
| Q3 2015 | $516,000 | -59.0% | 15,707 | -12.8% | 0.14% | -52.3% |
| Q2 2015 | $1,259,000 | -1.3% | 18,007 | -3.2% | 0.30% | -1.0% |
| Q1 2015 | $1,275,000 | -6.0% | 18,607 | +0.5% | 0.30% | -6.5% |
| Q4 2014 | $1,356,000 | -0.6% | 18,507 | -2.6% | 0.32% | -0.3% |
| Q3 2014 | $1,364,000 | +0.8% | 19,007 | +1.6% | 0.32% | +1.6% |
| Q2 2014 | $1,353,000 | -3.3% | 18,707 | -1.6% | 0.32% | -5.9% |
| Q1 2014 | $1,399,000 | +24.5% | 19,007 | +17.6% | 0.34% | +15.0% |
| Q4 2013 | $1,124,000 | +2.7% | 16,157 | -3.0% | 0.29% | -4.2% |
| Q3 2013 | $1,094,000 | -5.2% | 16,657 | 0.0% | 0.31% | -7.5% |
| Q2 2013 | $1,154,000 | – | 16,657 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |